Skip to main content
. 2006 Apr 19;2006(2):CD003241. doi: 10.1002/14651858.CD003241.pub2

Johansson 2001.

Methods Design: Randomised controlled trial. parallel groups 
 Randomisation: Computer generated random allocation. Allocation concealed in consecutively numbered opaque envelopes. Envelope opened by research therapist and not by local study co‐ordinator or evaluators. 
 Dropouts: At outcome measure 3 from TENS group (1 died, 1 adverse reaction, 1 unknown) and 5 from placebo group (3 died, 1 comorbidity, 1 at patient's own request).
Participants Experimental: n = 51, 45% female. Mean age 77 (SD9) years. 48 participants completed. 
 Control: n = 51, 51% female. Mean age 76 (SD 11) years. 46 participants completed. 
 Study criteria: (1) acute stroke 5 to 7 days before randomisation; (2) if recurrent stroke then no functional impairment before the present event; (3) Barthel Index 70 or less in combination with the inability to perform Nine Hole Peg Test within 60 seconds or inability to walk 10 metres without an aid or person support; (4) no previous neurological, psychiatric or other disorder making it difficult to pursue treatment or evaluations; (5) ability to comprehend information about the trial; (6) no concurrent participation in another trial of interventions supposed to affect neurological and functional outcome.
Interventions Duration: 30 minutes, twice a week for 10 weeks. 
 Experimental: 
 Category = 8 
 High‐intensity, low‐frequency (2Hz) TENS. The amplitude was strong enough to produce visible muscle contractions. All experimental participants also received conventional physiotherapy, occupational therapy and speech and language therapy if needed. 
 Control: 
 Subliminal high‐intensity, low‐frequency TENS. No skin sensation and no visible muscle contractions. All control participants also received conventional physiotherapy, occupational therapy and speech and language therapy if needed. 
 Comparison: electrostimulation vs placebo.
Outcomes Baseline measurement: Randomisation. 
 Outcome measurement: 3 months after stroke. 
 Included outcomes: (1) Rivermead Mobility Index; (2) walking speed; (3) Barthel Index. 
 Other outcomes: (1) ability to walk 10 metres; Nottingham Health profile quality of life domains.
Notes This was a 3‐group study but only 2 groups were included in this review. The acupuncture group was excluded because the control group was better matched to the other experimental group.
Intention‐to‐treat principle was followed in data analysis.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Low risk A ‐ Adequate